Health Summit Asia (HSA) 2026, set to take place from May 20–22 at the Kuala Lumpur Convention Centre, has confirmed more than 30 international speakers, positioning itself as Asia’s premier convergence point for AI-driven diagnostics, smart hospital innovation, and healthcare automation.
Technological Innovation
What distinguishes HSA 2026 from traditional medical conferences is its sharp focus on technologies already reshaping clinical practice — AI-enabled diagnostics, predictive health analytics, robotics-assisted surgery, and intelligent hospital infrastructure. The speaker lineup bridges research and real-world deployment, with Dr. Wilson Goh, Chief Data Scientist at NTU Singapore’s Centre of AI in Medicine, and Professor Mark Britnell, former Global Chair for Health at KPMG, among those set to map out the AI and data-driven future of medicine. Digital health platforms and hospital automation represent the event’s flagship technical themes.
Key Metrics and Scale
The confirmed roster of over 30 speakers spans public health, oncology, hospital management, and architectural design for health. Notable names include Tan Sri Dr Noor Hisham Abdullah, former Director-General of Health Malaysia, and Prof Dr Cheong Sok Ching, Chief Scientific Officer at Cancer Research Malaysia. The event merges two established platforms — SEACare, Malaysia’s leading B2B healthcare trade show, and the International Wellness Expo (IWE) — into a single three-day programme covering medical technology and wellness in parallel tracks.
Use Cases and Programme Highlights
Sessions will span AI-driven chronic disease prediction, biohacking, personalised longevity medicine, and functional medicine approaches to disease reversal. Dedicated Business Matching sessions are designed to connect medtech startups with global investors and policymakers, creating a structured pathway from proof-of-concept to market entry. This commercialization-focused architecture reflects the summit’s ambition to accelerate real-world adoption of healthcare AI.
Market Impact
Malaysia is rapidly emerging as Southeast Asia’s healthcare innovation hub, driven by accelerating digital health adoption, expanding AI diagnostic capabilities, and deepening public–private partnerships. HSA 2026 capitalises on this momentum by convening government, academia, industry, and investors under one roof — serving as a catalyst for the region’s broader digital health transformation.
Industry Perspective
Richard Teo, Executive Chairman of Qube Integrated Malaysia, framed the summit’s broader mission as one of knowledge exchange and empowerment, underscoring Malaysia’s ambition to anchor the region’s healthcare innovation dialogue.
